Avoid Warning Letters in View of the U.S. FDA's Stated Goal 2015
24 Mar 2015
Webinar
Avoid Warning Letters in View of the U.S. FDA's Stated Goal 2015 is an event that provides knowledge on avoid warning letters in view of the US FDA`s stated goal.
Key Topics
Proactive reviews of the applicable U.S. FDA / cGMP requirements
The U.S. FDA`s new aggressive implementation plans
FDA Inspectional Objectives
Key areas to focus limited resources
Recent trends and events
Common areas for critical mistakes
Q&A
The compliance audit
Who should Attend
Regulatory Affairs
Senior Management, Project Leaders
Internal and Supplier Auditor Personnel
Quality Systems Personnel
CAPA and P&PC personnel desiring to optimize systems and responses in harmony with the U.S. FDA`s quality management systems / cGMP expectations
R&D and Engineering Staff
Past Events
Avoid Warning Letters in View of the U.S. FDA's Stated Goal 2015 - 24 Mar 2015, Webinar (50482)
Avoid Warning Letters in View of the U.S. FDA`s Stated Goal 2026
Important
Please, check "Avoid Warning Letters in View of the U.S. FDA`s Stated Goal" official website for possible changes, before making any traveling arrangements
